Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
Lancet Respir Med
; 8(10): 987-999, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32653075
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Quinolones
/
Fluticasone-Salmeterol Drug Combination
/
Mometasone Furoate
/
Glucocorticoids
/
Indans
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Respir Med
Year:
2020
Document type:
Article
Country of publication: